ATORVASTATINE VIATRIS 10 mg, film-coated tablet 30 tablets, CIP 3400922284286
Active ingredients: Atorvastatin, Atorvastatin calcium trihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400922284286orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATORVASTATINE VIATRIS 10 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 9 Apr 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63644599CIP72228428CIP133400922284286Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ATORVASTATINEcomprimé | 10 mg · un comprimé | FT |
| ATORVASTATINE CALCIQUE TRIHYDRATÉEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.